Update on role of agalsidase alfa in management of Fabry disease.
about
Paediatric Fabry diseaseAgalsidase alfa: a review of its use in the management of Fabry diseaseEfficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients.Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative groupClinical course of patients with Fabry disease who were switched from agalsidase-β to agalsidase-αCerebral hemodynamics and endothelial function in patients with Fabry diseaseGastrointestinal Symptoms of Patients with Fabry Disease.Qualitative evaluation of the Canadian Fabry Disease InitiativeFabry disease: Evidence for a regional founder effect of the GLA gene mutation 30delG in Brazilian patients.Fabry disease: clinical and genotypic aspects of three cases in first degree relatives.Gene therapy for fabry disease: a review of the literature.Perspectives in Pediatric Pathology, Chapter 21. Testicular Pathology in Heritable Metabolic Disease.Auditing the frequency and the clinical and economic impact of testing for Fabry disease in patients under the age of 70 with a stroke admitted to Saint Vincent's University Hospital over a 6-month period.Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy.Diagnostic dilemma and delay in Fabry disease: insights from a case series of young female patients.
P2860
Q26770283-838FA7CA-6196-464B-A09C-4579CBF887BBQ28274194-5F8CC609-B3EB-4984-B98F-BE112F2476F0Q33776219-8CCD7843-161B-4221-A9E9-389CDC433C23Q33835524-C0509271-CEA4-4445-95A2-BFD36CC3DBFAQ34304963-C000490B-8EE2-495B-BDDC-0507C7FA63C1Q35037435-1CAF7731-45E7-4A61-9896-926DF08365EDQ36529707-653FF70A-B157-42CF-8801-AC9F0EC7F449Q36595910-17ABDC68-F991-435D-9C76-50D54FD72864Q37434242-3D1F6EC6-5B93-4D3A-B73F-85753CE3D5C4Q37609874-2E096177-DB8F-4006-BE91-31D4F6F9EC90Q38098070-8156E275-2754-48D7-AAF5-20B082E57279Q38264149-5A555E32-1104-4459-901A-9AAF91FD1806Q38687892-5FB159F8-2532-4C27-AB2B-78B97BBF5B8EQ41619077-C9BA249D-2794-4A46-B9D1-05B842F42CC5Q47818876-690B5598-FEA6-4861-B5AE-EA79C367A6CB
P2860
Update on role of agalsidase alfa in management of Fabry disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Update on role of agalsidase alfa in management of Fabry disease.
@ast
Update on role of agalsidase alfa in management of Fabry disease.
@en
Update on role of agalsidase alfa in management of Fabry disease.
@nl
type
label
Update on role of agalsidase alfa in management of Fabry disease.
@ast
Update on role of agalsidase alfa in management of Fabry disease.
@en
Update on role of agalsidase alfa in management of Fabry disease.
@nl
prefLabel
Update on role of agalsidase alfa in management of Fabry disease.
@ast
Update on role of agalsidase alfa in management of Fabry disease.
@en
Update on role of agalsidase alfa in management of Fabry disease.
@nl
P2860
P356
P1476
Update on role of agalsidase alfa in management of Fabry disease.
@en
P2093
Uma Ramaswami
P2860
P304
P356
10.2147/DDDT.S11985
P407
P577
2011-03-14T00:00:00Z